Avalyn Pharma Inc.
Clinical trials sponsored by Avalyn Pharma Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New inhaled therapy aims to slow lung scarring in IPF Results expected Dec 2026 (estimated)
- New inhaled therapy aims to slow lung scarring in progressive fibrosis Results expected Jun 2027 (estimated)